Artal Group’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Artal Group’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,030,952	Closed	-$1.87M	–	111
2024 Q2	$1.87M	Buy	3,030,952 +2,000,000	+194%	+$1.69M	0.05%	78
2024 Q1	$2.65M	Buy	+1,030,952	New	+$2.52M	0.07%	78
2023 Q1	–	Sell	-1,856,194	Closed	-$6.4M	–	147
2022 Q4	$6.4M	Buy	1,856,194 +1,106,194	+147%	+$3.16M	0.36%	54
2022 Q3	$1.93M	Hold	750,000	–	–	0.08%	96
2022 Q2	$1.81M	Hold	750,000	–	–	0.1%	102
2022 Q1	$3.09M	Hold	750,000	–	–	0.13%	102
2021 Q4	$9.64M	Buy	+750,000	New	+$8.31M	0.26%	71
2019 Q4	–	Sell	-250,000	Closed	-$2.16M	–	109
2019 Q3	$2.16M	Sell	250,000 -250,000	-50%	-$2.53M	0.09%	96
2019 Q2	$5.57M	Buy	500,000 +300,000	+150%	+$3.43M	0.23%	72
2019 Q1	$2.66M	Hold	200,000	–	–	0.11%	93
2018 Q4	$3.09M	Hold	200,000	–	–	0.11%	83
2018 Q3	$2.85M	Buy	+200,000	New	+$2.85M	0.07%	90

Other funds holding GRTS

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.3B AUM 21.14% 1-Year Est. Return

Artal Group's GRTS Position: Q3 2024 in Review

Artal Group sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2024, closing a stake of 3,030,952 shares — an estimated $1.87M sold.

Artal Group first reported a position in GRTS in Q3 2018 and held it in 12 quarters. The position peaked at $9.64M in Q4 2021. 56 funds tracked by Wall St. Rank hold GRTS as of Q3 2024.

Artal Group reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Artal Group sold 3,030,952 Gritstone bio, Inc. Common Stock shares in Q3 2024, an estimated $1.87M.
Artal Group first reported a position in Gritstone bio, Inc. Common Stock in Q3 2018 and held it in 12 quarters.
Artal Group's Gritstone bio, Inc. Common Stock position peaked at $9.64M in Q4 2021.
56 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2024.

Based on Artal Group's 13F filing for Q3 2024, filed 13 Nov 2024.